Services Sector Announces Monthly Sales Results, Dividends, New Products, Agreements and Appointments - Research Report on

  Services Sector Announces Monthly Sales Results, Dividends, New Products,
  Agreements and Appointments - Research Report on Target, CVS, COSTCO, Rite
                                 Aid, and GNC

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, August 7, 2013

NEW YORK, August 7, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Target
Corp. (NYSE: TGT), CVS Caremark Corporation (NYSE: CVS), Costco Wholesale
Corporation (NASDAQ: COST), Rite Aid Corp. (NYSE: RAD), and GNC Holdings Inc.
(NYSE: GNC). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

Target Corp. Research Report

On August 1, 2013, Target Corp. (Target) introduced the new Sonia Kashuk Bath
& Body Collection. Target informed that the new Bath & Body collection joins
Sonia Kashuk's luxury line of makeup and accessories. According to the
Company, the 24 new products are brought to life with four exquisite
fragrances created in collaboration by Sonia and perfumer extraordinaire,
Jérôme Epinette of Robertet. Further, Target stated that each of the
fragrance, Innocencia, Purple Seductia, Yellow Alluriana and Red Promisia, is
custom-made from the finest ingredients and are designed in partnership by
Sonia and the creative boutique agency Buero New York. The Full Research
Report on Target Corp. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-05/TGT]

--

CVS Caremark Corporation Research Report

On August 2, 2013, CVS Caremark Corporation (CVS) confirmed an agreement in
principle with the staff of the Boston Regional Office of the Securities and
Exchange Commission (SEC) to resolve an investigation by the SEC of certain
events that occurred in the year 2009. CVS informed that this investigation
focuses on events that occurred in Q3 2009 and Q4 2009, including certain
public disclosures made by CVS, transactions in the Company's securities by
certain current and former employees, and certain aspects of the purchase
accounting adjustment related to the October 2008 Longs Drug Stores
acquisition. According to the Company, the agreement in principle was reached
following extensive discussions with the SEC over the last several months and
the settlement remains subject to completion of final documentation and
approval by the Commission and federal court. CVS also reported that under the
terms of the agreement in principle, it will pay a $20 million civil penalty,
which has been fully reserved in CVS' financial statements and will not
require CVS Caremark to restate its earnings for any reporting period. The
Full Research Report on CVS Caremark Corporation - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.investorsreports.com/report/2013-08-05/CVS]

--

Costco Wholesale Corporation Research Report

On July 21, 2013, Costco Wholesale Corporation's (COSTCO) Board of Directors
declared a quarterly cash dividend on Costco common stock of $0.31 per share.
COSTCO reported that the quarterly dividend will be payable on August 23,
2013, to shareholders of record at the close of business on August 9, 2013.
The Full Research Report on Costco Wholesale Corporation - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-08-05/COST]

--

Rite Aid Corp. Research Report

On August 1, 2013, Rite Aid Corp. (Rite Aid) reported its sales results for
the month of July 2013 (four weeks period ended July 27, 2013). The Company's
same store sales increased 1.3% YoY, while front-end same store sales
increased 0.7% YoY in July 2013. Pharmacy same store sales, which included a
negative impact from new generic introductions of approximately 307 bps,
increased 1.6% YoY and prescription count at comparable stores increased 0.4%
YoY. On a year-to-date basis (21-week period ended July 27, 2013), same store
sales decreased 1.2% YoY; front-end same store sales increased 0.4% YoY;
pharmacy same store sales decreased 1.9% YoY, prescription count at comparable
stores was flat year-on-year; and total drugstore sales decreased 1.5% YoY to
$10.1 billion. The Full Research Report on Rite Aid Corp. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-08-05/RAD]

-

GNC Holdings Inc. Research Report

On July 29, 2013, GNC Holdings Inc. (GNC) announced the appointment of Carmine
Fortino as Executive Vice President for Business Development. Commenting on
the appointment, Joseph Fortunato, GNC's Chairman, President, and CEO, said,
"Carmine is a great addition to the GNC senior management team. His background
in multi-channel development across the health & wellness segment will enhance
our approach to new market opportunities as we continue to implement GNC's
proven growth strategy." The Full Research Report on GNC Holdings Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-05/GNC]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE Investors' Reports

Contact: CONTACT PERSON: Kristi Saunders, CONTACT PHONE: +1-315-982-6420
(North America)